Kai Long
5Patents
2h-index
24Co-inventors
43Inventor score
Filing activity: Sep 20, 2011 → May 8, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11518810B2 | Bispecific recombinant protein and use thereof | Chemistry; Metallurgy | 2 | Active |
| US9815841B2 | Compounds | Chemistry; Metallurgy | 2 | Active |
| US8975400B2 | 2,3-dihydroimidazo[1, 2-c] pyrimidin-5(1 H)-one compounds use as LP-PLA2 inhibitors | Human Necessities | 2 | Active |
| US9273054B2 | Substituted pyrimido[1,6-a]pyrimidines as Lp-PLA2 inhibitors | Human Necessities | 0 | Active |
| US8871928B2 | Tricyclic compounds, preparation methods, and their uses | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.